You are here

  • Home
  • Archive
  • Volume 81, Issue 6
  • Correspondence to ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’

Article info

Article menu

Download PDFPDF

Correspondence
Correspondence to ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’
Free

Authors

  • Kevin Sheng-Kai Ma Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA Department of Life Science, National Taiwan University, Taipei, Taiwan Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • James Cheng-Chung Wei Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan School of Clinical Medicine, Tsinghua University, Beijing, China PubMed articlesGoogle scholar articles
  • Wen-Hung Chung Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Taiwan Department of Dermatology, Chang Gung Memorial Hospital, Taipei, Taiwan College of Medicine, Chang Gung University, Taoyuan, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr. Wen-Hung Chung; chung1{at}cgmh.org.tw
View Full Text

Citation

Ma KS, Wei JC, Chung W
Correspondence to ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’
Annals of the Rheumatic Diseases 2022;81:e107.

Publication history

  • Received May 23, 2020
  • Accepted May 25, 2020
  • First published June 19, 2020.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.